Option Care Health, Inc. (NASDAQ:OPCH) Receives $29.86 Consensus Price Target from Brokerages

Shares of Option Care Health, Inc. (NASDAQ:OPCH) have received an average rating of “Moderate Buy” from the seven research firms that are presently covering the company, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price target among brokerages that have covered the stock in the last year is $29.86.

A number of research firms recently commented on OPCH. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their price target for the company from $26.00 to $33.00 in a report on Monday, January 13th. The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their price target for the company from $38.00 to $27.00 in a report on Monday, November 4th. UBS Group initiated coverage on shares of Option Care Health in a report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price target for the company. JMP Securities reissued a “market outperform” rating and set a $30.00 price objective (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Finally, Barrington Research boosted their price objective on shares of Option Care Health from $32.00 to $33.00 and gave the company an “outperform” rating in a research report on Tuesday, January 14th.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the stock in a transaction dated Friday, November 8th. The shares were purchased at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the purchase, the director now directly owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 0.64% of the company’s stock.

Institutional Investors Weigh In On Option Care Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in OPCH. UMB Bank n.a. raised its stake in Option Care Health by 937.5% during the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after acquiring an additional 750 shares during the period. GAMMA Investing LLC grew its holdings in Option Care Health by 110.6% during the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after buying an additional 471 shares in the last quarter. Whittier Trust Co. of Nevada Inc. grew its holdings in Option Care Health by 3,362.8% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock valued at $47,000 after buying an additional 1,446 shares in the last quarter. International Assets Investment Management LLC grew its holdings in Option Care Health by 3,029.7% during the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after buying an additional 2,757 shares in the last quarter. Finally, Quarry LP grew its holdings in shares of Option Care Health by 327.7% in the third quarter. Quarry LP now owns 3,430 shares of the company’s stock valued at $107,000 after purchasing an additional 2,628 shares in the last quarter. Institutional investors own 98.05% of the company’s stock.

Option Care Health Trading Down 0.5 %

NASDAQ:OPCH opened at $29.31 on Friday. The company has a fifty day moving average of $23.96 and a 200 day moving average of $27.77. Option Care Health has a 52 week low of $21.39 and a 52 week high of $34.63. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The firm has a market capitalization of $4.99 billion, a P/E ratio of 24.63, a P/E/G ratio of 2.09 and a beta of 1.31.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.